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Do amniotic fluid–derived stem cells differentiate into 
neurons in vitro?
To the editor:
Last year, De Coppi et al.1 reported that 
amniotic fluid–derived stem (AFS) cells can 
yield differentiated cells that express lineage-
specific markers and acquire 
characteristic functions 
in vitro. In particular, 
in addition to other cell 
types, they assert that AFS 
cells can give rise in vitro 
to neurons. To support 
this, the authors provide 
data indicating that AFS 
cells exposed to a medium 
that has been previously 
shown to promote neuronal 
differentiation express 
typical neuronal markers. 
They also show that they 
can record a barium-
sensitive potassium current from these cells 
and that the cells release glutamate. Given 
our specific competence and experience, we 
cannot comment on the characterization of 
nonneuronal types. We do think, however, 
that the presented data do not provide 
compelling evidence that AFS cells can 
specifically differentiate into neurons.
In this respect, several aspects of the results 
obtained by De Coppi et al. are of concern. 
First, the authors cite nestin as a marker “first 
defined in neural stem cells.” But nestin is 
not only expressed in neuroepithelial stem 
cells, but also in mesonephric mesenchyme, 
endothelial cells of developing blood vessels 
and kidney cells (see ref. 2 and references 
therein). In addition, in Figure 3a of the De 
Coppi et al. paper, the cytoskeletal staining of 
the intermediate filament nestin appears to 
be weak and atypical of the usual intracellular 
distribution of nestin.
Second, in our view, Figure 3b provides 
insufficient support for the claim that 
“individual cells (have) pyramidal 
morphology” (and does not confirm that 
the cells shown are neurons). The authors 
mention that the differentiation medium 
used has been shown previously to bias 
differentiation toward dopaminergic 
neurons3. However, no attempts are made 
at analyzing any of the markers related to 
the dopaminergic lineage (including a very 
obvious one, tyrosine 
hydroxylase).
Third, GIRK2 gene 
expression (Fig. 3c in 
the paper) cannot be 
considered a specific 
neuronal marker. GIRK 
(G-protein regulated 
inward-rectifier potassium) 
channels are hetero- or 
homotetrameric assemblies 
of different Kir3.0 and 
Kir3.2 subunits. The Kir3.2 
subunit (also termed 
GIRK2) possesses at least 
four isoforms that arise 
from differential splicing including Kir3.2a, 
Kir3.2b, Kir3.2c and Kir3.2d4–7. Kir3.2 
isoforms are widely distributed in different 
cell types and are not specific to neurons; in 
fact, Kir3.2b (GIRK2b) is considered to be 
ubiquitously expressed and Kir3.2d (GIRK2d) 
is expressed also in mouse testis6–8.
Fourth, by definition, GIRK channels are 
inward-rectifier potassium channels activated 
by G proteins following interaction between 
specific G proteins and agonists. In the 
absence of agonist, the background activity 
of GIRK channels is negligible, as clearly 
demonstrated by dose-response experiments 
(e.g., see refs. 9,10). The currents observed in 
the absence of agonist in Figure 3d of the De 
Coppi et al. paper suggest that a channel other 
than GIRK is active in these cells. It is possible 
that the agonist-independent currents result 
from activation of IRK (inward-rectifier 
potassium) channels, which are expressed 
in many cells types in addition to being 
expressed in neurons11.
Fifth, barium caused partial depression of 
current in the AFS-derived cells (Fig. 3e of the 
De Coppi et al. paper). Barium, however, is a 
nonspecific blocker of different K+ channel 
subtypes, including GIRK, IRK, K2p and 
some Kv channels12. These experiments 
cannot provide evidence that AFS cells 
develop into functional and active neurons.
And lastly, Figure 3f of their paper shows 
glutamate release from the AFS cells following 
growth in the differentiation medium. 
Glutamate can be released from astrocytes, 
osteoblasts, liver cells and neurons, and, 
as such, glutamate release is not a neuron-
specific property13–15.
The main feature that distinguishes 
neurons from other cell types is their ability 
to fire tetrodotoxin-sensitive action potentials 
with a characteristic shape and duration. 
To support the claim that AFS cells can 
differentiate into neurons, the authors could 
have used well-accepted approaches, such 
as determining whether (i) the cells express 
voltage-gated Na+ channels, (ii) the cells 
have a resting membrane potential close to 
values expected for excitable cells and below 
the voltage for Na+ channel steady-state 
inactivation, (iii) channel activation elicits 
tetrodotoxin-sensitive Na+ current and 
(iv) the generation of sizeable Na+ currents 
correlates with the capability of the cells to 
produce action potentials. One more critical 
parameter for the identification of neurons 
from undifferentiated stem cells could be 
the demonstration of synapses by electron 
microscopy. This is another hard marker 
of neuron identity not observed in Tuj1+ 
neuron-like populations obtained from 
nonneural sources.
De Coppi et al. also present initial studies 
suggesting that AFS cells directed toward 
a neural lineage are able to widely engraft 
into the developing mouse brain (Fig. 
4a–f from their paper). To us, the pictures 
presented only indicate that the authors are 
able to localize the donor cells within the 
choroid plexus and in close proximity to the 
ventricles using an antibody that recognizes 
the donor human cells. No claims about 
integration can be raised on the basis of 
the data presented. In addition, the author 
made no attempt to show that donor cells 
develop characteristic neuronal markers or 
CORRESPONDENCE
270 VOLUME 26   NUMBER 3   MARCH 2008   NATURE BIOTECHNOLOGY
morphology. Indeed, considering that donor 
cells have been exclusively visualized by an 
antibody against a 65-kDa mitochondrial 
protein with perinuclear localization, it 
is difficult to understand the claim that 
transplanted cells “integrate seamlessly and 
appear morphologically indistinguishable 
from surrounding murine cells,” which were 
only labelled by the nuclear stain DAPI (4’-6-
diamidino-2-phenylindole).
In conclusion, in our view the article by De 
Coppi et al. fails to provide any convincing 
evidence to support the claim that AFS cells 
are able to generate neurons. Given the 
medical and ethical impact of such claims, 
it is important that the contention that AFS 
cells can generate functional neurons be fully 
substantiated.
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Evan Y Snyder, Paolo De Coppi,  
Shay Soker & Anthony Atala respond:
We thank Toselli et al. for their comments 
on the neuronal differentiation of AFS 
cells. The goal of our report in Nature 
Biotechnology was to demonstrate that 
stem cells isolated from amniotic fluid 
are capable of self-renewal and of 
differentiation toward lineage pathways 
corresponding to the three embryonic germ 
layers1. Accordingly, we provided evidence 
that multiple, independent isolates of 
human AFS cells “were able to differentiate 
along adipogenic, osteogenic, myogenic, 
endothelial, neurogenic and hepatic 
pathways.” Within this group, the early 
neurogenic pathway served as the example 
for the ability to yield cells derived in 
development from the ectoderm. We further 
used retroviral marking to conclude that the 
multipotentiality of AFS cells with respect to 
the three germ layers is a clonal property.
Although we have observed the 
expression by induced AFS cells of markers 
consistent with the neuroectodermal 
lineage, including genes important for the 
generation of dopamine neurons, we agree 
that the findings to date do not show the 
production of mature neurons. The data 
in our report represent work in progress 
toward that end. Indeed, we sought to 
distinguish in our language between the 
generation of a mature, differentiated 
cell type and corresponding tissue (e.g., 
osteoblasts and bone) and the expression 
of markers and functions consistent with 
earlier stages of cell differentiation (e.g., 
hepatocytic or neuronal lineage). Below, we 
respond to the detailed concerns of Toselli 
et al. regarding the ability of AFS cells to 
differentiate into neurons in vitro.
First, Toselli et al. are correct that 
expression of nestin is not restricted to 
neuroepithelial progenitor cells. In our 
paper, we showed the expression of nestin 
by AFS cells induced under two conditions 
found previously to bias to neurectodermal 
differentiation and of GIRK2 mRNA 
(which they mention as a third concern) 
under conditions that promote the 
differentiation of embryonic stem (ES) 
cells toward dopaminergic neurons. We 
believe that the intensity of staining and 
the intracellular distribution of nestin, 
primarily in intermediate filaments, that we 
have observed repeatedly in putative neural 
progenitors derived from AFS cells are indeed 
comparable to what has been reported in the 
literature for neural stem cells obtained from 
the central nervous system.
Second, we did not claim that the cells 
shown in Figure 3b of our paper were 
functional neurons. To date, we have not 
observed differentiation of AFS cells to a 
mature neuronal phenotype. We will present 
elsewhere evidence for the expression of a 
variety of lineage markers consistent with 
the potential to progress in this direction, 
including class III beta-tubulin (β-Tub III) 
and the microtubule-associated protein 
2 (MAP2)2–9. We also have observed 
expression in induced cells of transcription 
factors important for the development of 
dopaminergic neurons, including Nurr1, 
pitx3 and Lmx1a10–18. We continue to seek 
conditions that promote robust expression 
of features of a mature neuronal phenotype, 
including action potentials, and specifically 
of dopaminergic neurons.
As noted by Toselli et al., the expression 
of GIRK2 and the presence of a barium-
sensitive potassium current do not 
define cells as neurons. However, the 
electrophysiological protocol employed 
has been used extensively in characterizing 
GIRK2 channels in neurons in hippocampus 
and also dopamine cells in substantia 
nigra and the ventral tegmental area of the 
brain19. The demonstration of a GIRK2-
like current after in vitro differentiation is 
consistent with the potential for AFS cells 
to develop toward a neuronal phenotype. 
As suggested, there remains the necessity 
to demonstrate expression and functional 
capacity of voltage-sensitive sodium channels 
before cells generated from AFS cells can be 
identified as functional neurons20.
Toselli et al. also point out that glutamate 
release is not neuron specific and can occur 
in astrocytes, osteoblasts and liver cells. 
The conditions used in the experiments 
showing glutamate release were based on 
previous literature reporting neural lineage 
differentiation of various multipotent 
stem cells and differ substantially from 
conditions we found to promote osteogenic 
or hepatogenic differentiation of AFS cells 
or reported to do so for other stem cells. A 
distinction between an astrocyte-like or a 
neuron-like phenotype would not alter the 
conclusion that AFS cells can be induced 
to differentiate along a neuroectodermal 
lineage.
The intracranial transplant experiments 
reported in our paper were in keeping with 
the overall aim of showing that AFS cells can 
yield derivatives representing each of the 
three germ layers. A first obvious goal of the 
transplantation study was to rule out the 
formation of tumors. This was accomplished. 
Second, we wished to determine whether 
the cells could intermix with and behave 
similarly to endogenous neural progenitors 
in a neural germinal zone over the period 
of time observed, achieving at least one 
threshold to support the entrance of AFS cell 
derivatives into a neuroectodermal lineage. 
When implanted into the cerebral ventricles 
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at birth, donor human AFS cells did, in fact, 
distribute throughout the periventricular 
germinal zone. The donor cells intermixed 
with endogenous neural progenitors and 
began to migrate, in concert with endogenous 
cells, along established migratory routes 
to appropriate targets, for example, the 
olfactory bulb. The observed migration of 
AFS-derived cells is not a general property of 
human cells implanted into the developing 
mouse brain but reflects lineage-appropriate 
behavior. By contrast, human fibroblasts 
transplanted at birth into the cerebral 
ventricles of mice fail to migrate and largely 
die21. The detailed characterization of fates of 
AFS cells implanted into the brain remains a 
work in progress.
In summary, we agree that it remains to 
be proven that AFS cells can differentiate 
to yield mature neurons and did not make 
such a claim in our published report. We 
believe that the evidence presented supports 
the conclusion that AFS cells are capable 
of entering the neuroectodermal lineage. 
The generation of action potentials and 
the assessment of the therapeutic potential 
of AFS-derived cells in animal models of 
neurodegeneration represent future goals. 
Together with evidence for the generation 
of lineages corresponding to endoderm and 
mesoderm, the data support the potential 
of AFS cell derivatives to enter the three 
fundamental embryonic germ layers. We also 
showed that AFS cells are capable of extensive 
self-renewal. Amniotic fluid has long been 
known to contain heterogeneous fetal cells 
of widely differing lineages and degrees of 
maturation. The population in amniotic fluid 
includes stem cells that may have washed out 
from the embryo at its early developmental 
stages, though they are more mature than 
those from the inner cell mass. The ability 
to reproducibly recover these AFS cells by a 
one-step immunoselection procedure from 
material that otherwise would be discarded 
offers a potentially valuable resource for 
exploring basic and clinical applications.
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